Perceptive Advisors’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-77,725
Closed -$428K 237
2016
Q4
$428K Hold
77,725
0.03% 128
2016
Q3
$589K Buy
+77,725
New +$568K 0.04% 111

Other funds holding IMDZ

Perceptive Advisors's IMDZ Position: Q1 2017 in Review

Perceptive Advisors sold out of Immune Design Corp. (IMDZ) in Q1 2017, closing a stake of 77,725 shares — an estimated $428K sold.

Perceptive Advisors first reported a position in IMDZ in Q3 2016 and held it in 2 quarters. The position peaked at $589K in Q3 2016. 58 funds tracked by Wall St. Rank hold IMDZ as of Q1 2017.

  • Perceptive Advisors reported no remaining Immune Design Corp. position as of Q1 2017 after selling out during the quarter.
  • Perceptive Advisors sold 77,725 Immune Design Corp. shares in Q1 2017, an estimated $428K.
  • Perceptive Advisors first reported a position in Immune Design Corp. in Q3 2016 and held it in 2 quarters.
  • Perceptive Advisors's Immune Design Corp. position peaked at $589K in Q3 2016.
  • 58 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.